Generex (GNBT) review
Crystal Research, and independent research company has just issued a 64-page research report on Generex Biotechnology. Crystal Research “is an independent research service company dedicated to increasing the visibility of innovative and growing private and public companies that represent extraordinary investment opportunities. Regardless of the size of the client, our independent research and advisory services provide additional value and assistance in realizing a company’s goals, enabling it to achieve its fullest potential.”
They focus on companies with “solid growth prospects, well-designed operating and growth strategies, an experienced and proven management team, command of a niche position in a large and expanding market, and a unique or innovative position or technology.”
After looking at some of the other companies that Crystal Research has covered, it appears that they mainly cover smaller BioTech companies.
This research report is free for anyone who wants to read it. You can access this report here.
In the review, they mention many things that are in Generex’s favor. There are currently 246 million people with diabetes worldwide. They also mention that diabetes is the 4th leading cause of death in the world. Since Generex’s product targets diabetes victims, this provides an excellent potential customer base for them.
Tags: crystal research, generex, gnbt, research report